| |
Characteristics of the patients
|
|---|
| |
(n = 41)
|
|---|
|
Age, years
|
|
Median (range)
|
66 (40–78)
|
|
Sex
|
|
Female/male
|
18 / 23
|
|
PS 0
|
24
|
|
PS 1
|
17
|
|
Smoking
|
|
Never
|
2
|
|
Previous
|
29
|
|
Active during RT
|
10
|
|
Histopathology
|
|
Adenocarcinoma
|
18
|
|
Squamous cell carcinoma
|
14
|
|
NSCLC, other type
|
9
|
|
8th TNM stage
|
|
IIA
|
1
|
|
IIB
|
1
|
|
IIIA
|
11
|
|
IIIB
|
14
|
|
IIIC
|
7
|
|
IVA
|
1
|
|
No tumor (post-op. RT)
|
6
|
|
Chemotherapy*
|
|
Concomitant in 3 cycles
|
31
|
|
Induction in 3–4 cycles
|
8
|
|
None
|
2
|
|
Radiation therapy dose
|
|
60 Gy / 30 fx
|
13
|
|
66 Gy / 33 fx
|
28
|
|
Radiation therapy type
|
|
3D conformal
|
39
|
|
IMRT
|
2
|
|
Radiation therapy side
|
|
Left
|
13
|
|
Right
|
28
|
|
Radiation therapy lobe localisation
|
|
Upper
|
23
|
|
Middle/lower
|
18
|
- PS, performance status; NSCLC, non-small cell lung cancer; post-op. RT, post-operative radiation therapy; TNM, tumour, node, metastasis; fx, fractions; 3D, 3 dimensional; IMRT, intensity-modulated radiation therapy
- *Chemotherapy included Carboplatin (i.v.) and Vinorelbine (p.o.)
